Clinical trial Recruiting at 5 sites Observational Ages 18 to 45 Women only

Investigating the role of hormones and microbiome in pregnancy during assisted reproduction

Official title: Prospective, Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase and Pregnancy After Embryo Transfer in Assisted Reproduction

Run by University of Luebeck · NCT03507673 · Data updated 2026-11-12

This study is trying to see how hormone levels and the bacteria in the vagina and uterus affect early pregnancy in women undergoing assisted reproduction with frozen embryos.

More Infertility trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment1200 (estimated)
SponsorUniversity of Luebeck
Academic / other
Locations5 sites (Saarbrücken, Saarland and 4 other locations)
StatusRecruiting
StartedMay 2, 2018
Main results expectedAugust 31, 2027
Study endsJune 30, 2028
Registry record updatedMay 22, 2025
Trial IDNCT03507673 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18 to 45 who are undergoing the transfer of cryopreserved embryos.

Probably not a fit

Patients undergoing fresh IVF/ICSI embryo transfers or those with uterine malformations or endometrial abnormalities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between progesterone levels and the vaginal/endometrial microbiome during the luteal phase in patients undergoing assisted reproduction. It focuses on determining the timing of the luteoplacental shift, which is crucial for maintaining early pregnancy. Blood samples and microbiological swabs will be collected from participants who are transferring cryopreserved embryos to assess these associations. The study seeks to fill gaps in understanding how hormonal and microbiological factors may influence pregnancy outcomes.

Why it matters

Potential benefit: If successful, this study could enhance understanding of factors affecting pregnancy maintenance, potentially leading to improved fertility treatments.

How similar studies have gone: While some studies have explored aspects of the microbiome in relation to fertility, this specific investigation into the interplay between progesterone and the microbiome during the luteal phase is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged 18 to 45 years
2. Transfer of cryopreserved embryos

Exclusion Criteria:

1. Fresh IVF/ICSI embryo transfer cycle
2. Evidence for ovulation on ultrasound previous to embryo transfer confirmed by a follicle ≥14mm or by a progesterone ≥1.0 µg/l in programmed cycles
3. Uterus malformations, endometrial abnormalities (on ultrasound or diagnosed by previous hysteroscopy)

Where it's running

  • Ivf-Saar
    Saarbrücken, Saarland, Germany
    Recruiting
  • Universitäres Kinderwunschzentrum Lübeck
    Lübeck, Schleswig-Holstein, Germany
    Recruiting
  • Universitätsklinikum Düsseldorf,UniKiD
    Düsseldorf, Germany
    Recruiting
  • Universitäres Kinderwunschzentrum
    Kiel, Germany
    Recruiting
  • University of Luebeck
    Lübeck, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.